Chronic obstructive pulmonary disease: the assessment of a therapist’s knowledge. The results of the ASCO-II study

DOI: https://doi.org/10.29296/25877305-2020-07-13
Download full text PDF
Issue: 
7
Year: 
2020

R. Bontsevich, Candidate of Medical Sciences(1); A. Shershneva(1); Ya. Vovk(1); T.
Filinichenko(1); G. Prozorova(2), MD; Professor A. Kirichenko(3), MD; E. Ebzeeva(3), Candidate of Medical
Sciences; O. Kompaniets(4), Candidate of Medical Sciences; Professor V. Nevzorova(5), MD; I. Martynenko(5),
Candidate of Medical Sciences; Professor G. Ketova(6), MD; V. Barysheva(6), Candidate of Medical Sciences;
E. Luchinina(7), Candidate of Medical Sciences; I. Galkina(8), Candidate of Medical Sciences; M.
Maksimov(9), MD; E. Mironenko(1)0, Candidate of Medical Sciences (1)Belgorod State National Research
University (2)N.N. Burdenko Voronezh State Medical University (3)Russian Medical Academy of Continuing
Professional Education, Moscow (4)Kuban State Medical University, Krasnodar (5)Pacific State Medical
University, Vladivostok (6)South Ural State Medical University, Chelyabinsk (7)V.I. Razumovsky Saratov State
Medical University (8)Polyclinic Six, Smolensk (9)Kazan State Medical Academy, Branch, Russian Medical
Academy of Continuing Professional Education 10Dnepropetrovsk Medical Academy (State Institution), Dnipro,
Ukraine

Objective: to determine the level of therapists’ basic knowledge about the management of patients with chronic obstructive pulmonary disease (COPD). Material and methods. This study analyzed an anonymous multicenter survey within the ASCO project for the management of COPD patients. Results. The study revealed an insufficiently high level of therapists’ knowledge about the management of patients with COPD. When answering the questions, the respondents showed the smallest results in selecting laboratory and instrumental ones showing evidence of severe COPD symptoms; in indicating drugs for the basic therapy of COPD with obvious symptoms and a high risk of exacerbations; in selecting the clinical group (type) of COPD for the following criteria: 60% forced expiratory volume in one second, one exacerbation per year, mMRC-1, and CAT-9 and in choosing the appropriate statement regarding COPD treatment/control. Conclusion. An analysis of the study results revealed an insufficient level of specialists’ basic knowledge about COPD, which, in the authors’ opinion, necessitates additional educational measures in this area among the practitioners.
Keywords: 
questioning survey
pulmonology
chronic obstructive pulmonary disease
physicians
level of knowledge
pharmacoepidemiology

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. The Global Initiative for Chronic Obstructive Lung Disease, 2017. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. URL: www.goldcopd.com
  2. Agafonova O.V., Gritsenko T.A., Bogdanova Ju.V. i dr. Poliklinicheskaja terapija: Uchebnik. Pod red. D.I. Davydkina, Ju.V. Schukina. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2020; 840 s. [Agafonova O.V., Gritsenko T.A., Bogdanova Yu.V. et al. Poliklinicheskaya terapiya: Uchebnik. Pod red. D.I. Davydkina, Yu.V. Shchukina. 2-e izd., pererab. i dop. M.: GEOTAR-Media, 2020; 840 s. (in Russ.)] DOI: 10.33029/9704-5545-6-PLT-2020-1-840
  3. World Health Organization. Evidence-informed policy-making, 2016. URL: http://www.who.int/evidence
  4. Buist A.S., McBurnie M.A., Vollmer W.M. International variation in the prevalence of COPD (the BOLD Study): a population based prevalence study. Lancet. 2007; 370 (9589): 741–50. DOI: 10.1016/S0140-6736(07)61377-4
  5. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2017; 5 (9): 691–706. DOI: 10.1016/S2213-2600(17)30293-X
  6. Hronicheskaja obstruktivnaja bolezn' legkih. Klinicheskie rekomendatsii. Rossijskoe respiratornoe obschestvo, 2018 [Khronicheskaya obstruktivnaya bolezn’ legkikh. Klinicheskie rekomendatsii. Rossiiskoe respiratornoe obshchestvo, 2018 (in Russ.)]. URL: http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/
  7. Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J COPD. 2014; 12: 963–74. DOI: 10.2147/COPD.S67283
  8. Bontsevich R.A., Shershneva A.S., Filinichenko T.S.; pravoobladatel' FGAOU VO «Belgorodskij gosudarstvennyj natsional'nyj issledovatel'skij universitet». Svidetel'stvo o gosudarstvennoj registratsii bazy dannyh №2020620448 Rossijskaja Federatsija. Hronicheskaja obstruktivnaja bolezn' legkih: etiopatogenez, diagnostika i lechenie – uroven' znanij vrachej. №2020620277 zajavl. 06.03.2020; zaregistr. 11.03.2020; 1 s. [Bontsevich R.A., Shershneva A.S., Filinichenko T.S.; pravoobladatel’ FGAOU VO «Belgorodskii gosudarstvennyi natsional’nyi issledovatel’skii universitet». Svidetel’stvo o gosudarstvennoi registratsii bazy dannykh №2020620448 Rossiiskaya Federatsiya. Khronicheskaya obstruktivnaya bolezn’ legkikh: etiopatogenez, diagnostika i lechenie – uroven’ znanii vrachei. №2020620277 zayavl. 06.03.2020; zaregistr. 11.03.2020; 1 s. (in Russ.)].
  9. Bontsevich R., Gashynova K., Kompaniets O. et al. Assessment of physicians and undergraduates in COPD: ASCO-2 study. Eur Respir J. 2018; 52 (Suppl. 62): 3136. DOI: 10.1183/13993003.congress-2018.PA3136
  10. Bontsevich R., Filinichenko T., Gavrilova A. i dr. Otsenka bazovyh znanij o hronicheskoj obstruktivnoj bolezni legkih vrachej terapevticheskogo profilja. Rezul'taty proekta ASCO-II. Vrach. 2018; 29 (12): 46–50 [Bontsevich R., Filinichenko T., Gavrilova A. et al. Assessment of the therapists’ basic knowledge of chronic obstructive pulmonary disease: Results of the ASCO-II project. Vrach. 2018; 29 (12): 46–50 (in Russ.)]. https://doi.org/10.29296/25877305-2018-12-11
  11. Bontsevich R.A., Filinichenko T.S., Vovk Y.R. et al. Comparative assessment of physicians’ and senior medical students’ basic knowledge in treatment of chronic obstructive pulmonary disease. Research Results in Pharmacology. 2019; 5 (1): 67–75. https://doi.org/10.3897/rrpharmacology.5.34072
  12. Bontsevich R.A., Schurovskaja K.V., Pokrovskaja T.G. i dr. Otsenka bazovyh znanij v voprosah HOBL u studentov starshih kursov – final'nye rezul'taty issledovanija ASCO. Farmateka. 2018; 8: 72–8 [Bontsevich R.A., Shchurovskaya K.V., Pokrovskaya T.G. et al. Estimation of basic knowledge of COPD issues in graduate students – final results of ASCO study. Farmateka. 2018; 8: 72–8 (in Russ.)]. DOI: https: //dx.doi.org/10.18565/pharmateca.2018.8.72-78
  13. Respiratornaja meditsina. Rukovodstvo: v 3 t. Pod red. A.G. Chuchalina. M.: Littera, 2017 [Respiratornaya meditsina. Rukovodstvo: v 3 t. Pod red. A.G. Chuchalina. M.: Littera, 2017 (in Russ.)].
  14. Hurst J.R. Vestbo J., Anzueto A., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363: 1128–38. DOI: 10.1056/NEJMoa0909883 Hill K., Goldstein R.S., Guyatt G.H. et al. Prevalence and underdiagnosis of chronic obstructive pulmonary diseaseamong patients at risk im primary care. CMAJ. 2010; 182 (7): 673–8. DOI: 10.1503/cmaj.091784
  15. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Revised 2011. URL: www.goldcopd.com